Philip Morris
Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
Fields
- Author
- Ecobichon, D.J.
- Wexler, L.M.
- Wu, J.M.
- Wexler, L.M.
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- BIBL, BIBLIOGRAPHY
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Characteristic
- EXTR, EXTRA
- MARG, MARGINALIA
- Named Person
- Wexler, L.M.
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Author (Organization)
- Intl Symposium Environment Tobacco Smoke
- Mcgill Univ
- Ny Medical College
- Mcgill Univ
- Site
- R529
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- nic02a00
Document Images
ETS and Cardiovascular Disease 147
le
Ir
The results compared ETS exposed husband's and non-ETS exposed hus-
bands, where the husbands had never smoked. None of the endpoints showed'
statistical significance between the two groups, before or after adjustment for
several variables, including age, baseline blood pressure,,chol'esterol, weight,
alcohol consumption and education.
However, within the exposed group, increasing levels of cigarettes
smoked daily by the wife had a statistically significant dose response re-
lationship with husbands' CHD deaths. This is technically significant (p =
0.04) but is based on only one death in the 1-19 cigarettes smoked/day cate-
gory.
A second analysis lumped never smoking husbands with ex-smoking hus-
bands, calling these non-smoking husbands. This group was then evaluated
on the basis of the smoking status of the wife. Non-smoking, husbands of
smokers did not show a statistically significant result when compared with
husbands of non-smoking wives for mortality from CHD (p = 0:15) or from
CHD itself as an endpoint (p =.10)L
Several methodological problems exist in the Svendsen report. One prob-
lem is possible misclassification of husband's smoking status either at entry
or subsequently: A second problem is that the wife's smoking status was based
on interviews with the husband, andi not on direct questioning of the wife.
There is also an alcohol}related bias, as MRFIT ETS-exposed husbands'
had two drinks per week, on average, more than non-ETS exposed husbands,
and this alcohol! effect could explain the observed statistical significance in,
dose response.
Finally, by combining ex-smoking husbands with never smokers, Svend-
sen confounds any past effects of active smoking by the husband with expo-
sure to ETS.
The MRFIT study serves as an exemplary prospective trial for its design
and conduct. However,, lack of statistical significance, failure to control for
several confounding variables (such as alcohol consumption), mi'sclassifica-
tion, and misgrouping make it difficult to draw any conclusions from the
study.
5. Helsing. The Helsing (1988) paper examines death certificates collected
from July 1963 through July 1975 for a population living im July 1963 in
Washington County, Maryland; This is based: on underlying cause of death
of arteriosclerotic heart disease including coronary disease (International
Classification of Disease [1CD] -420) and other myocardial' degeneratiom
(1CD 422)i As of July 15, 1963, 98% of the residents were asked questions
that included information on sex, age, race, marital status, years of schooling,
housing characteristics, information on cigarette, cigar and' pipe smoking
habits, as welli as frequency of church, attendance, for each household mem-
ber aged 16.5 years or older.
Among 22,973' white men and 25,369 white women 25 years of age and

148 Envi.onmental Tobacco Smoke
older in the 1963 census, 4,1162 men and 14,873 women reported'that they
had never smoked. The 1971 follow-up population was a subset of these
numbers: 3,4541 men and 12,345 women.
The results showed that death rates from, arteriosclerotic heart, disease
were higher among men (relative risk = 1.31) and women (relative risk =
1.24)who lived with smokers in 1963, after adjustment for age, marital sta-
tus, years of schooling and qualiry of housing index. For women, relative risk
increased significantly (p <.005): with increasing 1'evel's of exposure,, but for
men, there was little evidence of' a dose response relationship.
Several methodological' problems exist with the Helsing paper. The first
major problem is that the only smoking data that was collected on every
person was in~ 1963, Hence, no changes in smoking habits over the 12-year
period were ascertained. In additiony no data were collected on other risk
factors for heart disease such as diet, exercise, blood pressure and cholesterol'.
Finally, no ETS exposure outside the home was measured:
B. Case-Control Study
1. Lee.,The Lee (1986) study is a case control (retrospective) study to eval,
uate the possible relationship between cigarette smoking and risk of lung
cancer, chronic bronchitis, ischemic heart disease and stroke. The original
questionnaire was administered in ten hospital regions in England; between
1977 and 1982. Although not recorded initially, ETS exposure data was sub-
sequently collected in 1979 for married ~ patients in the last four regions.
Two hundred cases and 200 matched controls were collected'for each sex
(male, female) and age (35-44, 45-54, 55-64, and 65-74)', grouping to ex-
amine the possible relationship between ETS exposure and diagnosis of isch-
emic heart disease. Also matched were hospital region ands when possible,
}iospital i war&and time of interview.
Ischemic heart disease cases and controls did not show a statistically sig-
nificant difference in, their exposure to ETS, based either on smoking habits
of spouses or on an index accounting for exposure at home, at work, and
during travel and leisure..
Although the Lee study is one of the few to attempt to examine non-
spousal ETS exposure, it raises the general methodological issues that sur-
round retrospective case control studies. In its finding of non-statisticali
significance for any trends of association between ETS and cardiovascular
illness, the Lee paper confirms the need for execution of better, controlled
prospective trials.
C. Experimental' Design
1. Aronow. The Aronow (1978), paper, describes an experimentaL design to
examine the possible relationship between exposure to ETS and exercise-in-
duced angina in both a well ventilated and an unventilated room.

ETS and Cardiovascular Disease 149
The design induded ten men (eight non-smokers and two smokers) who
exercised upright on a bicycle ergometer with a progressive work load until
the onset of angina pectoris. Subjects were randomized to three groups: noo
smoking, smoking in a well ventilated rooms or smoking in an unventilated
room.
Aronow has suggested that the results of his study demonstrate that, un-
der the conditions of the experiment, ETS exposure causes angina] pain to
develop soon after exercise. In addition, the data from the study indicate that
exposure to ETS causes an increase in carboxyhemoglobin, more after ETS
exposure im am unventilated room than~ after ETS exposure in a ventilated
room..
Severat major criticisms of the Aronow study include: (1) ~ the use of sub-
jective pain as an end point without double blinding; (2) a very small sample
size that can lead to a large variance based on just one or two subjects chang-
ing their responses, (3) problems associated with the Hawthorne effect [sub-
jects tend to produce symptoms suggested to them], and (4) failure to control
for stress.
D. Conclusions
The Surgeon General's Report of 1986 (1986) examined the studies of
Hirayama, Gillis, Garland and Aronow,, and concltyded that "further studies
on the relationship between involuntary smoking and cardiovascular disease
are needed in order to determine whether involuntary smoking increases the
risk of cardiovascvlar disease."
The National Research Council (1986): in 1986 reviewed the prospective
studies of Garland, Gillis, Hirayama and Svendsen, as well as severaliexper-
imental designs examining the biological plausibility of the association of
ETS and cardiovascular disease, and concluded that:
1. No statistically significant effects of ETS exposure on heart rate or blood
pressure were found inihealthy men, women, and school-aged children dur-
ing resting conditions. During exercise there is no difference in the cardio-
vascular changes for men and women between conditions of exposure to
ETS and control conditions.
2. With respecrto chronic cardiovascular morbidity and mortality, although
biologically plausiblethere is no evidence of statistically significant effectss
due to ETS exposure, apart from the study by Hirayama in Japan.
It is the opinion of' this author that none of the studies critiqued in this
paper provides any basis for altering the Surgeon General's and' NAS's con-
clusions concerning ETS and cardiovascular disease.
This conclusion is reinforced by the findings of Schieveblein and Richter
(1984). They report that, under real-life conditions, persons exposed to ETS
inhale only approximately .02 to .01 of the amount of particulate matter

150 Environmartat Tobacco Smoke
taken up by active smokers. Also, nicotine concentration in serum~ of ETS-
exposed individuals is within a range that is barely distinguishable from the
background level, and'the increase in carboxyhemoglobin rarely exceeds 1%.
The authors conclude that exposure to ETS "is not likely to have an effect on
the development and progression of CHD."
Il. Recommendations for Future Research
To provide meaningful recommendations for future research, it is necessary
to evaluate the existing studies of ETS exposure and cardiovascular disease
in light of the five criteria for causality discussed at the beginning of this
paper.
The NAS concluded that a relationship between ETS exposure and car-
diovascular disease is biologically plausible, and each of'the studies reviewed
in this paper appears to provide an adequate temporal association between
ETS exposure (as measured by spousal smoking) and the onset of cardiovas-
cular disease. However, the studies fail to meet one or more of the remaining
criteria for causality.
Of the six studies concerning ETS exposure and cardiovascular morbidity
and mortality, only two (1-lirayama and Helsing) 1 reported statistically signif~
icant relative risks for exposed' compared to nonexposed populations, and
neither study reporte& a relative risk greater than 2. Hirayama reported a
dose dependent relationship but Helsing did not.
None of the studies demonstrate a specificiry, of association between ETS
exposure and cardiovascular disease. Each of the studies fails to control for
one or more important confounding variables, including lifestyle, blood pres-
sure, serum cholesterol; obesity and socioeconomic status. None of the stud-
ies provides an accurate measurement of' ETS exposure. Alll of the studies
suffer from one or more serious methodological problems, including small
sample size and possible misclassification of spousal smoking status. These
confounding variables and methodological problems also preclude any dem-
onstration of consistency of association among the existing studies.
in view of' the inadequacy of existing studies, it is logical to consider
whether the Framingham Heart Study might provide an adequate basis for a
definitive evaluation of the relationship between ETS exposure and heart
disease.
The Framingham Heart Study, initiated during 1948-1950,,is comprised
of a study cohort from~ a random subsample of the adult residents of Fra-
mingham, Massachusetts, of which 69% responded~ No reports on ETS and
heart disease have been published under the Study, but spousal smoking hab-
its could be determined from the Study's data base. Although an effort could
be made to measure ETS effects on~ heart disease in the Framingham Study,
this would not be likelw to provide an adequate basis for a definitive evalu-
ation of' ETS an&hean disease.
I

ETS and Cardiovascular Disease 15l
The critical, problem is that the Framingham, Study does not provide a
basis for an accurate measurement of ETS exposure, especially outside of the
home. Use of'data on spousal smoking habits as a surrogate for, ETS exposure
has been shown to present serious methodological and other problems in
existing studies.
In any event, the recent paper by Seltzer (1989) suggests that the Fra-
mingham Study is not likely to; show a significant association between, ETS
exposure and heart disease. Seltzer's paper, compares the Surgeon General's
statements regarding the association between active smoking and heart dis-
ease with the data in the Framingham Study. Seltzer points out that the Fra-
mingham data differ from the Surgeon General's conclusions in several im-
portant respects:
1. The Surgeon General asserts a four-fold greater CHD incidence in men
who are heavy smokers as compared to non.smokers; Framingham re-
ports relative risk ratios less than two.
2. The Surgeon General asserts that cigarette smoking among women has a
predictive association ~ with CHD; Framingham finds no such~association.
3. The Surgeon General states there is an increase of CHD with increase of
duration of smoking; in the Fratningham Study, this increase is absent.
4. The SurgeomGeneral claims that rates of CHD eventually are reduced im
ex-smokers to:those somewhere between smokers and non-smokers, and
somedmes, after many years, falling to the level of non-smokers. The
Framingham data are surprising in that reductions in CHD among ex-
smokers is below levels for never smokers! This suggests that a selection
bias may exist.
Given the relatively small effect of active smoking on heart disease re-
ported in the Framingham Study, it appears unlikely that any effect of ETS
exposure on heart disease could be measured under that Study.
In view of the lack of adequate existing data, future studies need to be
performed that carefully examine the relationship between exposure to ETS
and cardiovascular disease. It is the hope of this author that the critiques
presented in this paper, examining many of the methodological problems as-
sociated with existing ETS epidemiological studies, will be of use to well-
traine&scientists. Familiarity with the five key points of causality in epide-
miology is critical in designing studies that can clearly show whether any
association exists between exposure to ETS and cardiovascular disease.
Based on the analysis in this paper, a meaningful future study should
contain at least the following elements:
1. A representative sample large enough to yield adequate statistical power.
2. A design that provides control'r for important confounding variables, in-

duding blood pressure, diet, alcohol consumption, plasma cholesterol,
body weight, sex, socioeconomic status and exposure to environmental
substances other than ETS.
3. A mechanism for accurate measurement of ETS exposure, including ex-
posure outside the home, and' adequate follow-up of exposure status.
4. A prospective desigm specifically developed to satisfy the criteria for
causality.
Aronow, W.S. (1978). Effects of passive smoking on~angina pectoris. New England
Journal of Medicine 299(1)21-24.
Environmental Tobacco Smoke - Measuring Exposures and Assessing Health Effects,
National Research, Council, National Academy Press, Washington, D.C.,1986.
Garland, C. et. al. (1985): Effects of passive smoking on, ischemic Heart disease mor-
tality of non-smokers. American Journal ofEputemiology 121(S).
Helsing, K.J,, D.P. Sandlers G.W. Comstock, and E. Chee, (1988). Heart disease mor-
tality in non-smokers Gvingwith smokers. American Journal of Epidemiology
127(5).
HirayamaT. (1984). Lung cancer in Japan: Effects of nutrition and passive smoking,
Lung Cancer: Causes and Prevention. Verlag Chemie Ihternational; Inc.
Hirayama, T. (1981). Non-Smoking wives of heavy smokers have a higher risk of
lung eancer: a study from Japan. British Medual Journal 282:183-185.
Holt, D.J., C.R. Gillis et. al. (1989). Passive smoking and cardiorespiratoryhealth in
a generallpopulhtion in the west of:Scotland. Brirish' Medical Journal 299:423-
427.
Lee, P.N:, J: Chamberdain, and~IvS.R. Alderson, (1986): Relationship of passive smok-
ing to risk of lung cancer and other smoking-associated diseases. British Journal'
of Cancer 54:97-105.
Schievelbein, H. and F. Richter (1984). The influence of passive smoking on the car-
diovascular system. Prevention Medicine, 13:626-b44.
Seltzer, C. (1989). Framingham study data andestablished wisdom about cigarette
smoking and coronary disease. Journal of Clinical Epidemiology 42(8):743-750:
Surgeon General's Report (1986)1 The Health Consequences of Involuntary Smoking.
U.S. Department of Health and Human Services.
Svendsen, K.H., Lewis H. Kuller et. al. (1987). Effects of passive smoking in the muW
tiple risk factor intervention trial: American Journal'of Epidemiology 126(5): (=
~.'i
r.~
~7
